OBJECTIVE
The Office of National Drug Control Policy circular: National Drug Control Program Agency Compliance Reviews requires agencies expending funds on National Drug Control Program activities to submit an accounting of such funds made during the previous fiscal year (21 U.S.C. § 1704). The policy also requires that an agency submit with its annual accounting an authentication provided by the agency's OIG that expresses a conclusion on the reliability of the agency's assertions. The circular states that if in an agency's prior year drug-related obligations were less than $50 million, the agency would not be subject to these authentication requirements. We will review how HHS agencies complied with this circular and will submit the authentication with respect to the HHS agencies' annual accounting, beginning with FY 2020, once every three years.
There are 7 projects in this series.
Project titles will remain unpublished until projects are complete and reports are posted.
ACTIVE PROJECTS IN THIS SERIES (2)
COMPLETED PROJECTS IN THIS SERIES (5)
OAS-26-03-023
OAS-26-03-024
OAS-26-03-025
CMS Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions
HRSA Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions
TIMELINE
-
October 29, 2024Projects Announced
CMS Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions - OAS-25-03-018
-
HRSA Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions - OAS-25-03-016
-
January 15, 2025Project Complete - OAS-25-03-018
CMS Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions complete. Report Published
-
January 15, 2025Project Complete - OAS-25-03-016
HRSA Fiscal Year 2024 Detailed Accounting Submission and Fiscal Year 2026 Budget Formulation Compliance Report for National Drug Control Activities, and the Accompanying Required Assertions complete. Report Published
-
December 19, 2025Series Number SRS-A-26-009 Assigned
-
December 19, 2025Projects Announced
OAS-26-03-023 - OAS-26-03-023
-
OAS-26-03-024 - OAS-26-03-024
-
OAS-26-03-025 - OAS-26-03-025
-
February 24, 2026Project Complete - OAS-26-03-023
OAS-26-03-023 complete. Report Published
-
February 24, 2026Project Complete - OAS-26-03-024
OAS-26-03-024 complete. Report Published
-
February 24, 2026Project Complete - OAS-26-03-025
OAS-26-03-025 complete. Report Published
-
February 24, 2026Series Complete
Mandatory Review of HHS Agencies' Annual Accounting of National Drug Control Program Funds complete.
-
November 2, 2026Projects Announced
Project OAS-27-03-007
-
Project OAS-27-03-008